Table 3. GSEA results showing pathways enriched in the top or bottom of the ranked list (part 2).
gsea_report_for_h_1569251519150 | ||||||
PATHWAY | SIZE | ES | NES | NOM p-val | FDR q-val | FWER p-val |
HALLMARK_KRAS_SIGNALING_UP | 200 | 0.68496144 | 2.5519905 | 0 | 0 | 0 |
HALLMARK_MYOGENESIS | 200 | 0.7163382 | 2.4803855 | 0 | 0 | 0 |
HALLMARK_INFLAMMATORY_RESPONSE | 200 | 0.74277735 | 2.4324496 | 0 | 0 | 0 |
HALLMARK_IL2_STAT5_SIGNALING | 200 | 0.64027786 | 2.404173 | 0 | 0 | 0 |
HALLMARK_APICAL_JUNCTION | 200 | 0.66379976 | 2.2760096 | 0 | 0 | 0 |
HALLMARK_COMPLEMENT | 200 | 0.64504373 | 2.269838 | 0 | 0 | 0 |
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 198 | 0.84459037 | 2.4160647 | 0 | 0 | 0 |
HALLMARK_UV_RESPONSE_DN | 142 | 0.7505294 | 2.5657384 | 0 | 0 | 0 |
HALLMARK_COAGULATION | 138 | 0.6745744 | 2.3511252 | 0 | 0 | 0 |
HALLMARK_TGF_BETA_SIGNALING | 54 | 0.7044607 | 2.3415003 | 0 | 0 | 0 |
HALLMARK_ANGIOGENESIS | 36 | 0.78319705 | 2.304125 | 0 | 0 | 0 |
HALLMARK_IL6_JAK_STAT3_SIGNALING | 87 | 0.7255876 | 2.219405 | 0 | 2.10E-04 | 0.003 |
HALLMARK_HEDGEHOG_SIGNALING | 36 | 0.70793414 | 2.135469 | 0 | 8.37E-04 | 0.008 |
HALLMARK_ALLOGRAFT_REJECTION | 200 | 0.6927329 | 2.1372313 | 0.0020243 | 9.02E-04 | 0.008 |
HALLMARK_NOTCH_SIGNALING | 32 | 0.64948887 | 2.1142936 | 0 | 0.001424 | 0.016 |
HALLMARK_APOPTOSIS | 161 | 0.5897472 | 2.1039493 | 0 | 0.0015353 | 0.018 |
HALLMARK_HYPOXIA | 197 | 0.5773829 | 2.0876963 | 0 | 0.0018728 | 0.024 |
HALLMARK_APICAL_SURFACE | 44 | 0.6299601 | 2.0555112 | 0.0019011 | 0.0022883 | 0.031 |
gsea_report_for_l_1569251519150 | ||||||
PATHWAY | SIZE | ES | NES | NOM p-val | FDR q-val | FWER p-val |
HALLMARK_OXIDATIVE_PHOSPHORYLATION | 200 | -0.81177884 | -2.1761758 | 0 | 0.0027603 | 0.007 |
HALLMARK_MYC_TARGETS_V1 | 199 | -0.7470366 | -1.9788883 | 0.004065 | 0.0174095 | 0.064 |
HALLMARK_MYC_TARGETS_V2 | 58 | -0.79232734 | -1.9486467 | 0.0041068 | 0.0176199 | 0.085 |